BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34288092)

  • 1. Identification of altered cell signaling pathways using proteomic profiling in stable and progressive chronic lymphocytic leukemia.
    Bagacean C; Iuga CA; Bordron A; Tempescul A; Pralea IE; Bernard D; Cornen M; Bergot T; Le Dantec C; Brooks W; Saad H; Ianotto JC; Pers JO; Zdrenghea M; Berthou C; Renaudineau Y
    J Leukoc Biol; 2022 Feb; 111(2):313-325. PubMed ID: 34288092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens.
    Liao W; Jordaan G; Nham P; Phan RT; Pelegrini M; Sharma S
    BMC Cancer; 2015 Oct; 15():714. PubMed ID: 26474785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multipronged functional proteomics approaches for global identification of altered cell signalling pathways in B-cell chronic lymphocytic leukaemia.
    Díez P; Lorenzo S; Dégano RM; Ibarrola N; González-González M; Nieto W; Almeida J; González M; Orfao A; Fuentes M
    Proteomics; 2016 Apr; 16(8):1193-203. PubMed ID: 26910488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein profiles distinguish stable and progressive chronic lymphocytic leukemia.
    Huang PY; Mactier S; Armacki N; Giles Best O; Belov L; Kaufman KL; Pascovici D; Mulligan SP; Christopherson RI
    Leuk Lymphoma; 2016 May; 57(5):1033-43. PubMed ID: 26422656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment.
    Admoni-Elisha L; Nakdimon I; Shteinfer A; Prezma T; Arif T; Arbel N; Melkov A; Zelichov O; Levi I; Shoshan-Barmatz V
    PLoS One; 2016; 11(4):e0148500. PubMed ID: 27078856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-cadherin gene re-expression in chronic lymphocytic leukemia cells by HDAC inhibitors.
    Jordaan G; Liao W; Sharma S
    BMC Cancer; 2013 Feb; 13():88. PubMed ID: 23432814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of reactive oxygen species-mediated signal transduction with in vitro apoptosis sensitivity in chronic lymphocytic leukemia B cells.
    Palazzo AL; Evensen E; Huang YW; Cesano A; Nolan GP; Fantl WJ
    PLoS One; 2011; 6(10):e24592. PubMed ID: 22016760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface phenotype profiles distinguish stable and progressive chronic lymphocytic leukemia.
    Huang PY; Best OG; Almazi JG; Belov L; Davis ZA; Majid A; Dyer MJ; Pascovici D; Mulligan SP; Christopherson RI
    Leuk Lymphoma; 2014 Sep; 55(9):2085-92. PubMed ID: 24289109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metadherin contributes to the pathogenesis of chronic lymphocytic leukemia partially through Wnt/β-catenin pathway.
    Li PP; Feng LL; Chen N; Ge XL; Lv X; Lu K; Ding M; Yuan D; Wang X
    Med Oncol; 2015 Feb; 32(2):479. PubMed ID: 25575438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZAP-70 protein expression in B-cell chronic lymphoid leukemia: a single center experience from Pakistan.
    Zeeshan R; Irfan SM; Sultan S; Bhimani S
    Asian Pac J Cancer Prev; 2015; 16(4):1587-90. PubMed ID: 25743836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia.
    Lu D; Zhao Y; Tawatao R; Cottam HB; Sen M; Leoni LM; Kipps TJ; Corr M; Carson DA
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3118-23. PubMed ID: 14973184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of key candidate genes and miRNA‑mRNA target pairs in chronic lymphocytic leukemia by integrated bioinformatics analysis.
    Gao C; Zhou C; Zhuang J; Liu L; Wei J; Liu C; Li H; Sun C
    Mol Med Rep; 2019 Jan; 19(1):362-374. PubMed ID: 30431072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD markers variations in chronic lymphocytic leukemia: New insights into prognosis.
    Vosoughi T; Bagheri M; Hosseinzadeh M; Ehsanpour A; Davari N; Saki N
    J Cell Physiol; 2019 Nov; 234(11):19420-19439. PubMed ID: 31049958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The autocrine motility factor receptor is overexpressed on the surface of B cells in Binet C chronic lymphocytic leukemia.
    Grund S; Olsson B; Jernås M; Jacobsson S; Swolin B; Nabi IR; Carlsson L; Wadenvik H
    Med Oncol; 2011 Dec; 28(4):1542-8. PubMed ID: 20574759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies
    Rani L; Mathur N; Gupta R; Gogia A; Kaur G; Dhanjal JK; Sundar D; Kumar L; Sharma A
    Clin Epigenetics; 2017; 9():57. PubMed ID: 28572861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors.
    Sharma S; Pavlasova GM; Seda V; Cerna KA; Vojackova E; Filip D; Ondrisova L; Sandova V; Kostalova L; Zeni PF; Borsky M; Oppelt J; Liskova K; Kren L; Janikova A; Pospisilova S; Fernandes SM; Shehata M; Rassenti LZ; Jaeger U; Doubek M; Davids MS; Brown JR; Mayer J; Kipps TJ; Mraz M
    Blood; 2021 May; 137(18):2481-2494. PubMed ID: 33171493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia.
    Ferreira PG; Jares P; Rico D; Gómez-López G; Martínez-Trillos A; Villamor N; Ecker S; González-Pérez A; Knowles DG; Monlong J; Johnson R; Quesada V; Djebali S; Papasaikas P; López-Guerra M; Colomer D; Royo C; Cazorla M; Pinyol M; Clot G; Aymerich M; Rozman M; Kulis M; Tamborero D; Gouin A; Blanc J; Gut M; Gut I; Puente XS; Pisano DG; Martin-Subero JI; López-Bigas N; López-Guillermo A; Valencia A; López-Otín C; Campo E; Guigó R
    Genome Res; 2014 Feb; 24(2):212-26. PubMed ID: 24265505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of
    Biran A; Yin S; Kretzmer H; Ten Hacken E; Parvin S; Lucas F; Uduman M; Gutierrez C; Dangle N; Billington L; Regis FF; Rassenti LZ; Mohammad A; Hoffmann GB; Stevenson K; Zheng M; Witten E; Fernandes SM; Tausch E; Sun C; Stilgenbauer S; Brown JR; Kipps TJ; Aster JC; Gnirke A; Neuberg DS; Letai A; Wang L; Carrasco RD; Meissner A; Wu CJ
    Cancer Res; 2021 Dec; 81(24):6117-6130. PubMed ID: 34686499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia.
    Cavallini C; Lovato O; Bertolaso A; Zoratti E; Malpeli G; Mimiola E; Tinelli M; Aprili F; Tecchio C; Perbellini O; Scarpa A; Zamò A; Cassatella MA; Pizzolo G; Scupoli MT
    Oncotarget; 2015 Oct; 6(31):32061-74. PubMed ID: 26393680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.
    Rybka J; Butrym A; Wróbel T; Jaźwiec B; Bogucka-Fedorczuk A; Poręba R; Kuliczkowski K
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):147-150. PubMed ID: 28083607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.